PMID: 10543756Oct 30, 1999Paper

Emergence and dissemination of quinolone-resistant Escherichia coli in the community

Antimicrobial Agents and Chemotherapy
J GarauA Ruíz-Bremón

Abstract

We studied the evolution of resistance to quinolones in Escherichia coli from 1992 to 1997 in Barcelona, Spain. An increasing proportion of quinolone-resistant E. coli (QREC) infections was observed. QREC strains were more common in patients with nosocomial infections but also increased in patients with community-acquired infections (9% in 1992 to 17% in 1996). Seventy (12%) of 572 episodes of E. coli bacteremia were due to QREC. Factors significantly associated with QREC bacteremia were the presence of underlying disease, recent exposure to antibiotics, and bacteremia of unknown origin. In the multivariate analysis, only prior exposure to antimicrobial agents (P < 0.001; odds ratio [OR] = 2), specifically, to quinolones (P < 0. 001; OR = 14), and the presence of a urinary catheter (P < 0.001; OR = 2) were significantly associated with QREC bacteremia. Among 16 QREC isolates from cultures of blood of community origin selected at random, 13 different pulsed-field gel electrophoresis patterns were recognized, showing the genetic diversity of these isolates and in turn indicating the independent emergence of QREC in the community. The prevalence of QREC in the feces of healthy people was unexpectedly high (24% in adults and 26% in...Continue Reading

References

Jun 1, 1977·Royal Society of Health Journal·A H Linton
Apr 1, 1989·The Journal of Antimicrobial Chemotherapy·L J Piddock, R Wise
May 1, 1987·Reviews of Infectious Diseases·C M KuninV Thamlikitkul
Mar 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J CarrataláF Gudiol
Apr 28, 1994·The New England Journal of Medicine·A ComettaM P Glauser
Oct 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F Baquero
Feb 1, 1997·The Journal of Antimicrobial Chemotherapy·A P Johnson
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H YooD J Kim
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B CampilloG Leluan

❮ Previous
Next ❯

Citations

Apr 20, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·J Y ChenC F Peng
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·X Zhao, K Drlica
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Annarita MazzariolRoberta Fontana
Sep 16, 2003·Emerging Infectious Diseases·Beatriz MirelisGuillem Prats
Nov 12, 2003·Emerging Infectious Diseases·Guillem PratsLluís Salleras
Jun 23, 2004·Emerging Infectious Diseases·Karine GrenetAntoine Andremont
Aug 28, 2004·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·W S HartM D Barton
Mar 10, 2005·Basic & Clinical Pharmacology & Toxicology·Frank M Aarestrup
Jul 20, 2007·Environmental Health Perspectives·Lance B PriceEllen Silbergeld
Sep 4, 2007·Applied and Environmental Microbiology·Thi Thu Hao VanPeter J Coloe
Apr 29, 2008·The Tohoku Journal of Experimental Medicine·Ming-Chung KoChung-Yi Li
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A TalanUNKNOWN EMERGEncy ID NET Study Group
Aug 13, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Bernard C CaminsVictoria J Fraser
Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Dec 31, 2014·Veterinary Medicine International·Reza TalebiyanMohammad Rabiee-Faradonbeh
Jun 11, 2019·Frontiers in Medicine·Krishna Prasad Acharya, R Trevor Wilson
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Javier FernándezJuan Rodés
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shahla Mansouri, Sorreia Shareifi
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Elena DomínguezCarmen Torres
Dec 10, 2003·Journal of Medical Microbiology·Feng-Jui ChenHsiu-Jung Lo
Jun 8, 2001·Paediatric Drugs·D Gendrel, F Moulin
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Conan MacDougallRonald E Polk
Jul 16, 2005·The Journal of Antimicrobial Chemotherapy·Patrice Nordmann, Laurent Poirel
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
Nov 16, 2001·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·E Mateu, M Martin
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Oct 19, 2005·Emerging Infectious Diseases·Kuntaman KuntamanUNKNOWN Antimicrobial Resistance in Indonesia, Prevalence and Prevention Study Group
Jan 31, 2008·Leukemia & Lymphoma·Sarah P Hammond, Lindsey R Baden
Jan 21, 2006·Emerging Infectious Diseases·Peter Collignon
Jun 21, 2005·Emerging Infectious Diseases·John M StellingStuart B Levy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
H J CheongS C Park
Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Joong-Sik EomHee-Jin Cheong
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Eric BatardFrançoise Ballereau
Antimicrobial Agents and Chemotherapy
Mussaret B ZaidiMarcia L Headrick
© 2021 Meta ULC. All rights reserved